Recombinant human interleukin 12 (BBCA Pharmaceutical)
重组人白细胞介素12（丰原药业）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant human interleukin 12 (BBCA Pharmaceutical)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesMaanshan Fengyuan Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A